What to Know About This $130,000 Amalgamated Financial Insider Sale After Shares Rose 49% This regional banking provider, known for its diversified financial services, reported a notable insider sale in its latest SEC filing.
2 Biotech Stocks Worth Buying Before Their Potential Buyouts It has been a banner year for biotech buyouts, and these are two of the prime targets.
DiamondRock Hospitality Stock Is Up 61%. Here's What This Insider Sale Could Mean This hotel REIT, known for its diversified upscale portfolio, reported a notable insider sale amid strong recent share performance.
Steven Madden Stock Is Up 81%. Should Investors Care About This Director's Sale? Steven Madden, a footwear and accessories leader, reported a notable insider sale amid strong one-year share price performance.
Is PayPal Stock Cheap, or a Value Trap? Although the fintech stock trades at a price-to-earnings ratio of 7.8, there is ongoing debate about its investment merits.
Why This $1.8 Million Dime Insider Sale May Matter Less Than Its 67% EPS Growth This New York regional bank, known for its commercial lending focus, reported significant insider selling in the latest SEC filing.
Where Will Nvidia Stock Be in 2030? The AI build-out turned the chipmaker into a giant -- but how much longer can the spending last?
Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy. Intuitive Surgical has been a huge winner over the long term, but there's a potential opening for new investors right now.
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction. This healthcare technology firm, focused on Medicare Advantage plans, reported a notable insider sale amid muted stock performance.
Vesta Director Sells $203,000 in Stock While Shares Gain 25% in a Year This Mexican industrial real estate firm reported a notable insider sale following a year of strong share price gains and stable growth.
Where Will Solana Be in 3 Years? The world's fastest blockchain could attract a lot more attention.
This Vanguard Index Fund Could Be the Best Financial Decision You Ever Make Setting yourself up for a lifetime of wealth doesn't need to be complicated. Buy this ETF and you'll be well on your way!
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests Focused on regenerative therapies for sports medicine and burn care, this biopharma firm reported a notable insider sale in June.
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally This genomics diagnostics specialist, up over 120% in a year, reported a notable insider sale amid ongoing scheduled dispositions.
SpaceX Stock Will Join The Nasdaq-100 Index On July 7 Passive funds tracking the Nasdaq 100 will buy nearly $3 billion worth of SpaceX.
This U.S. Uranium Miner Just Became a Critical Minerals Play. But Is the Stock a Buy? Energy Fuels is entering the critical minerals space as the U.S. seeks to secure domestic sources of these important materials.
Why Most Digital Marketing Agencies Are Failing Their Clients — And What to Look For Instead IntroductionThis is a difficult blog post for a digital marketing agency to write.Because we're about to tell you the truth about our own industry —Most di
Digital Marketing Agency vs Freelancer vs In-House Team: What's Best for Your Business? IntroductionYou've decided your Raipur business needs serious digital marketing help.But now you face another decision —"Should I hire a digital marketing
What to Know About This $3.3 Million Intuitive Machines Insider Sale as Space Stocks Heat Up Houston’s lunar exploration specialist reported a notable insider sale amid ongoing contract-driven growth in the aerospace sector.
How to Save Money on Your Medicare Prescription Drugs Healthcare is one of a retiree's largest expenses. Here are six ways to minimize prescription costs.
Solar Beats Coal for the First Time: 3 Dividend Stocks to Buy Now Solar power generated more electricity than coal in May; this could be a sign to buy clean energy stocks.
What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally Focused on rare skin disease therapies, this clinical-stage biotech just reported a notable insider sale amid a year of sharp stock gains.
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally Focused on cancer therapies, this Boulder-based biotech reported significant insider selling amid a year of sharp share price gains.
Here's How Investing $450 Per Month Could Generate More Than $30,000 in Annual Dividends The Schwab U.S. Dividend Equity ETF is a solid option for investors who want a quality investment that can generate lots of dividend income.
